The Basilar Artery International Cooperation Study (BASICS)

International Journal of Stroke

Volumn 2, Issue 3, 2007, Pages 220-223

  Schonewille, Wouter J ^a   Wijman, Christine A C ^b   Michel, Patrik ^c   Algra, Ale ^a   Kappelle, L Jaap ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Stanford California and Cofounder   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Basilar artery; Outcome; Registry; Stroke; Treatment

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HEPARIN; UROKINASE;

ARTERIOGRAPHY; ARTERY OCCLUSION; ARTICLE; BASILAR ARTERY; CASE STUDY; CLINICAL TRIAL; FATALITY; HUMAN; MONOTHERAPY; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REGISTER; STROKE; SURVIVAL; SYMPTOMATOLOGY;

FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; VERTEBROBASILAR INSUFFICIENCY;

EID: 34547115961     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2007.00145.x     Document Type: Article

References (31)

1. Kubik CS, Adams RD: Occlusion of the basilar artery - a clinical and pathologic study. Brain 1946; 69:73-121.
2. Moscow NP, Newton TH: Angiographic implications in diagnosis and prognosis of basilar artery occlusion. Am J Roentgenol Radium Ther Mucl Med 1973; 119:597-603.
3. Archer CR, Horenstein S: Basilar artery occlusion. Clinical and radiological correlation. Stroke 1977; 8:383-90.
4. Devuyst G, Bogousslavsky J, Meuli R et al. Stroke or transient ischemic attacks with basilar artery stenosis or occlusion. Clinical patterns and outcome. Arch Neurol 2002; 59:567-73.
5. Zeumer H, Hacke W, Ringelstein EB: Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease. Am J Neuroradiol 1983; 4:401-4.
6. Bruckmann H, Ferbert A, del Zoppo GJ, Hacke W, Zeumer H: Acute vertebral-basilar thrombosis: Angiologic-clinical comparison and therapeutic implications. Acta Radiol 1986; 369(Suppl.): 38-42.
7. Hacke W, Zeumer H, Ferbert A, Bruckmann H, del Zoppo GJ: Intra-arterial thrombolitic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988; 19:1216-22.
8. Brandt T, von Kummer R, Müller-Küppers M, Hacke W: Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996; 27:875-81.
9. Wijdicks EF, Nichols DA, Thielen KR et al. Intra-arterial thrombolysis in acute basilar artery thromboembolism: The initial Mayo Clinic experience. Mayo Clin Proc 1997; 72:1005-13.
10. Cross DT III, Moran CJ, Atkins PT, Angtuaco EE, Diringer MN: Relationship between clot location and outcome after basilar artery thrombolysis. Am J Neuradiol 1997; 18:1221-8.
11. Gönner F, Remonda L, Mattle H et al. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke 1998; 29:1894-900.
12. Berg-Dammer E, Felber SR, Henkes H, Nahser HC, Kühne D: Long-term outcome after local intra-arterial fibrinolysis of basilar artery thrombosis. Cerebrovasc Dis 2000; 10:183-8.
13. Sliwka U, Mull M, Stelzer A, Diehl R: Long-term follow-up of patients after intraarterial thrombolytic therapy of acute vertebrobasilar artery occlusion. Cerebrovasc Dis 2001; 12:214-9.
14. Eckert B, Kucinski T, Pfeiffer G, Groden C, Zeumer H: Endovascular therapy of acute vertebrobasilar occlusion: Early treatment onset as the most important factor. Cerebrovasc Dis 2002; 14:42-50.
15. Arnold M, Nedeltchev K, Schroth G et al. Clinical and radiological predictors of recanalization and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004; 75:857-62.
16. Lindsberg PJ, Soinne L, Tatlisumak T et al. Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA 2004; 292:1862-6.
17. Schonewille WJ, Algra A, Serena J, Molina CA, Kappelle LJ: Outcome in patients with basilar artery occlusion treated conventionally. J. Neurol Neurosurg Psychiatry 2005; 76:1238-41.
18. Lindsberg PJ, Mattle HP: Therapy of basilar artery occlusion. A systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 2006; 37:922-8.
19. Macleod MR, Davis SM, Mitchell PJ et al. Results of a multicentre, randomized controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis 2005; 20:12-7.
20. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274:1017-25.
21. Hacke W, Kaste M, Fieschi C et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study investigators. Lancet 1998; 352:1245-51.
22. Tissue plasminogen activator for acute ischemic stroke: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333:1581-7.
23. Hacke W, Donnan G, Fieschi C et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA Stroke Trials. Lancet 2004; 363:768-74.
24. Furlan A, Higashida R, Wechsler L et al. For the PROACT Investigators: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II Study: A randomized controlled trial. JAMA 1999; 282:2003-11.
25. Lewandowski CA, Frankel M, Toomsick TA et al. and the EMS bridging trial investigators: Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischaemic stroke. Emergency Management of Stroke (EMS) bridging trial. Stroke 1999; 30:2598-605.
26. The IMS study investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The interventional management of stroke study. Stroke 2004; 35:904-12.
27. Hacke W, Albers G, Al-Rawi Y et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005; 36:66-73.
28. Ribo M, Molina CA, Rovira A et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3 to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 2005; 36:602-6.
29. Albers GW, Thijs VN, Wechsler L et al. MRI profiles predict clinical response to early reperfusion: The DEFUSE study. Ann Neurol 2006; 60:508-17.
30. Furlan AJ, Eyding D, Albers GW et al. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9-hours after stroke onset. Stroke 2006; 37:1227-31.
31. Ostrem JL, Saver JL, Alger JR et al. Acute basilar artery occlusion: diffusion-perfusion MRI characterization of tissue salvage in patients receiving intra-arterial stroke therapies. Stroke 2004; 35:30-34.